<DOC>
	<DOCNO>NCT00003688</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness dactinomycin treat patient persistent recurrent gestational trophoblastic neoplasia .</brief_summary>
	<brief_title>Dactinomycin Treating Patients With Persistent Recurrent Gestational Trophoblastic Neoplasia</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy dactinomycin patient persistent recurrent low-risk gestational trophoblastic neoplasia . - Determine toxicity drug patient . OUTLINE : This multicenter study . Patients receive dactinomycin IV 15 minute day 1 . Treatment repeat every 2 week absence unacceptable toxicity . Patients achieve normal beta-human chorionic gonadotropin ( HCG ) receive 2 additional course attain normal beta-HCG . Patients follow every 2 week 2 month monthly 10 month . PROJECTED ACCRUAL : A total 15-35 patient accrue study within 18-42 month .</detailed_description>
	<mesh_term>Trophoblastic Neoplasms</mesh_term>
	<mesh_term>Gestational Trophoblastic Disease</mesh_term>
	<mesh_term>Dactinomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm complete partial mole initial evaluation Current diagnosis persistent recurrent lowrisk gestational trophoblastic neoplasia , define 1 follow criterion : Less 10 % fall betahuman chorionic gonadotropin ( HCG ) 3 consecutive weekly titer More 20 % rise betaHCG previous value time Rise betaHCG ( great 5 mU/mL ) attain normal level Prior treatment limited methotrexate ( MTX ) without leucovorin calcium ( CF ) WHO score 26 time relapse Must undergone least 1 prior curettage diagnosis initial management No metastatic disease lung vagina physical examination , chemistry , chest xray , ultrasound No 8 metastatic lesion No histologically confirm placental site trophoblastic tumor initial evaluation PATIENT CHARACTERISTICS : Age 12 50 Performance status GOG 01 Life expectancy Not specify Hematopoietic WBC least 3,000/mm^3 Platelet count least 100,000/mm^3 Granulocyte count least 1,500/mm^3 Hepatic Bilirubin great 1.5 time normal SGOT great 3 time normal Alkaline phosphatase great 3 time normal Renal Creatinine great 1.5 mg/dL Other No significant infection No 1 year since prior pregnancy Fertile patient must use effective contraception No invasive malignancy within past 5 year except nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics At least 1 week since prior chemotherapy recover No prior chemotherapeutic drug MTX without CF Endocrine therapy Not specify Radiotherapy Not specify Surgery See Disease Characteristics Recovered prior surgery No concurrent curettage unless require control vaginal bleeding Other No prior anticancer treatment would preclude study therapy</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>recurrent gestational trophoblastic tumor</keyword>
	<keyword>nonmetastatic gestational trophoblastic tumor</keyword>
	<keyword>low risk metastatic gestational trophoblastic tumor</keyword>
</DOC>